Imovane

Zopiclone, the active ingredient in Imovane, is a cyclopyrrolone presented as an oral tablet for oral use. It treats insomnia by helping adults fall asleep and stay asleep. GNH USA supplies Imovane as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Zopiclone is a hypnotic agent used to manage sleep disorders.

- Insomnia: helps initiate and maintain sleep in adults. - Primary insomnia: provides short‑term relief of difficulty falling asleep. - Adjustment insomnia: aids sleep during periods of stress or environmental change.

Zopiclone may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Drowsiness or excessive sleepiness. - Dry mouth. - Bitter or metallic taste. - Headache. - Dizziness. - Nausea or abdominal discomfort.

Serious or Rare Side Effects: - Complex sleep behaviors such as sleep‑walking or driving while asleep. - Allergic reactions including rash, swelling, or anaphylaxis. - Mood changes, depression, or suicidal thoughts. - Memory impairment or amnesia. - Respiratory depression, especially when combined with other depressants. - Severe hypotension or cardiac arrhythmias.

When prescribing Zopiclone, several safety considerations should be observed.

- Pregnancy: Category C; use only if potential benefit justifies the potential risk to the fetus. - Elderly patients: increased sensitivity; start with the lowest effective dose and monitor closely. - Driving and operating machinery: avoid until the individual knows how the drug affects them. - Alcohol: avoid concurrent consumption as it may enhance sedative effects. - Renal or hepatic impairment: dose adjustment may be necessary based on clinical assessment. - Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Zopiclone can interact with other medicines, affecting its sedative effect or plasma concentration.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, opioids): additive sedation and respiratory depression. - Alcohol: potentiates central nervous system depression. - Macrolide antibiotics (erythromycin, clarithromycin): may increase Zopiclone plasma levels.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (fluoxetine, fluvoxamine): may raise Zopiclone concentrations. - Cimetidine: can reduce hepatic clearance, leading to higher exposure. - Carbamazepine: may decrease Zopiclone effectiveness by inducing metabolism.